ADO and viral infectious disease: This observation might be exclusive for COVID-19 patients, because patients with other viral infection as influenza A, although presenting elevated proinflammatory nucleotides, maintain normal production of anti‐inflammatory ADO, and do not show elevated levels of CD39.